Testosterone Cypionate Injection — Class II drug recall D-0420-2025
Ongoing recall by Empower Clinic Services, LLC dba Empower Pharmacy, reported 2025-05-21, distributed nationwide. Lack of Assurance of Sterility
| Recall number | D-0420-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Empower Clinic Services, LLC dba Empower Pharmacy, Houston, TX, United States |
| Recall initiated | 2025-05-02 |
| Classified | 2025-05-09 |
| Reported by FDA | 2025-05-21 |
| Distributed | Nationwide (US) |
| Quantity | 8,230 vials |
| Reason classes | sterility |
| Lot numbers | 202364 |
| Expiration dates | 2025-05-28 |
Product
Testosterone Cypionate Injection, 200 mg/mL, CIII, Rx Only, 5 mL Sterile Multiple-Dose Vial, Compounded by: Empower Pharmacy, 7601 N Sam Houston Pkwy W Ste 100, Houston, TX, 77064, Phone: (877) 562-8577, Compounding Date: 08/20/2024, Beyond Use by Date: 05/28/2025, Lot 202364.
Reason for recall
Lack of Assurance of Sterility
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0420-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.